Advantages over traditional moss
We use a never-before-applied moss species engineered for faster growth, higher yields, and better protein expression than standard moss systems. This means superior performance and efficiency in every batch.
Our moss is robust, stable, and adaptable for industrial-scale production. It tolerates bioreactor conditions better, ensuring consistent therapeutic compound output year-round.
What makes Adaptive Biologics unique?
What makes Adaptive Biologics unique? Adaptive Biologics is the first company to harness a proprietary new moss species optimized for therapeutic biopharming. We have developed a next-generation platform that significantly outperforms both traditional moss systems and conventional bacterial, yeast, and mammalian cell platforms — delivering higher protein yields, superior human-like glycosylation, greater scalability, and substantially lower manufacturing costs.
Designed for industrial production, our system enables the efficient and consistent manufacturing of complex biologics that have been difficult or uneconomical to produce with existing technologies. This breakthrough positions Adaptive Biologics at the forefront of safer, more affordable, and more effective next-generation therapeutics.
Company
Home
About
Contact
Resources
Careers
Blog
Support